Related Experiment Videos
Prevention of iron deficiency in preterm neonates during infancy
H D Heese1, S Smith, S Watermeyer
1Department of Paediatrics and Child Health, University of Cape Town.
Insights
Preventing iron deficiency in preterm infants is crucial. Both oral iron and intramuscular iron dextran effectively benefited most infants, offering options when oral compliance is a concern.
Area of Science:
- Neonatal Medicine
- Pediatric Nutrition
- Hematology
Background:
- Preterm infants are at high risk for iron deficiency due to limited iron stores and rapid growth.
- Oral iron supplementation is standard but requires consistent administration, which can be challenging.
- Intramuscular iron dextran presents an alternative when oral compliance is uncertain.
Purpose of the Study:
- To compare the effectiveness of oral iron versus intramuscular iron dextran in preventing iron deficiency in premature infants.
- To evaluate the efficacy of two distinct iron supplementation strategies in a vulnerable infant population.
Main Methods:
- A study involving two groups of healthy premature infants.
- Group 1 received oral iron (2 mg/kg/d) until 6 months of age.
- Group 2 received a single dose of intramuscular iron dextran (100 mg) between 6 and 8 weeks of age.
Main Results:
- Both oral iron supplementation and intramuscular iron dextran administration demonstrated benefits for the majority of infants studied.
- The study suggests that both methods are effective in addressing iron deficiency in prematurity.
Conclusions:
- Supplementary iron is essential for preterm infants to prevent iron deficiency.
- Both oral and intramuscular iron dextran are effective strategies for iron supplementation in preterm infants.
- Intramuscular iron dextran offers a viable alternative when oral iron compliance is a potential issue.
Abstract:
The preterm infant inevitably develops iron deficiency unless supplementary iron is given. Oral iron supplementation is preferred in ideal social circumstances but, where compliance with such therapy is uncertain, intramuscular iron dextran may be a more effective treatment. A study was conducted to compare the effectiveness of two methods of preventing iron deficiency of prematurity. One group of healthy premature infants was given oral iron 2 mg/kg/d until the age of 6 months. The second similar group was given 100 mg as intramuscular iron dextran (Imferon; Fisons) between the ages of 6 and 8 weeks. Both kinds of supplementary iron appeared to have benefited the majority of infants in this trial.